Data gathered: March 25
AI Stock Analysis - Eli Lilly and Company (LLY)
Analysis generated January 4, 2025. Powered by Chat GPT.
Eli Lilly and Company (NYSE: LLY) is a leading pharmaceutical company known for its innovation in healthcare solutions. Established in 1876, Eli Lilly has a rich history of developing life-changing medications, including drugs for diabetes, cancer, and autoimmune diseases. With a strong focus on research and development, Eli Lilly has consistently delivered new treatments that address critical health challenges globally. The company operates in numerous segments including human pharmaceuticals and animal health, serving markets worldwide.
Stock Alerts - Eli Lilly and Company (LLY)
 |
Eli Lilly and Company | March 18 AI Score is up by 29.9% in the last couple of days. |
|
Eli Lilly and Company | March 15 AI Score is up by 25.4% in the last couple of days. |
|
Eli Lilly and Company | March 14 Insider Alert: Zakrowski Donald A is selling shares |
|
Eli Lilly and Company | March 7 Price is down by -5.1% in the last 24h. |
Alternative Data for Eli Lilly and Company
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,065 | Sign up | Sign up | Sign up |
| Sentiment | 85 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,140,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 31 | Sign up | Sign up | Sign up |
| Patents | 451 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2,395 | Sign up | Sign up | Sign up |
| Facebook Followers | 250,655 | Sign up | Sign up | Sign up |
| Instagram Followers | 42,067 | Sign up | Sign up | Sign up |
| Reddit Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 146 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 24,197 | Sign up | Sign up | Sign up |
| Twitter Followers | 142,753 | Sign up | Sign up | Sign up |
| Twitter Mentions | 263 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 66 | Sign up | Sign up | Sign up |
| Business Outlook | 84 | Sign up | Sign up | Sign up |
| Linkedin Employees | 48,166 | Sign up | Sign up | Sign up |
About Eli Lilly and Company
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
| Price | $852.35 |
| Target Price | Sign up |
| Volume | 2,670,000 |
| Market Cap | $777B |
| Year Range | $724.43 - $956.65 |
| Dividend Yield | 0.72% |
| PE Ratio | 73.73 |
| Analyst Rating | 89% buy |
| Industry | Drug Manufacturers |
In the news
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and CompanyMarch 25 - Financial Post |
|
Is Eli Lilly and Company (NYSE:LLY) The Best Stocks to Buy Now For the Long Term?March 25 - Yahoo Entertainment |
|
 |
Leerink Partnrs Issues Optimistic Forecast for LLY EarningsMarch 24 - ETF Daily News |
 |
Was Jim Cramer Right About Eli Lilly and Company (LLY)?March 24 - Yahoo |
|
Is Eli Lilly and Company (LLY) The Best Healthcare Dividend Stock to Invest in?March 23 - Yahoo |
|
Is Eli Lilly and Company (LLY) The Best Robinhood Stock to Buy According to Analysts?March 22 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 13.5B | 5.61B | 7.92B | 4.41B | 6.15B | 5.320 |
| Q3 '24 | 11.4B | 4.24B | 7.2B | 970M | 2.25B | 1.180 |
| Q2 '24 | 11.3B | 4.61B | 6.69B | 2.97B | 4.12B | 3.920 |
| Q1 '24 | 8.77B | 3.51B | 5.26B | 2.24B | 3.12B | 2.580 |
| Q4 '23 | 9.35B | 4.17B | 5.18B | 2.19B | 3.03B | 2.490 |
Insider Transactions View All
| Zakrowski Donald A filed to sell 5,840 shares at $818.2. March 13 '25 |
| LILLY ENDOWMENT INC filed to sell 96,016,978 shares at $934.9. March 4 '25 |
| LILLY ENDOWMENT INC filed to sell 96,198,597 shares at $925.6. March 4 '25 |
| LILLY ENDOWMENT INC filed to sell 96,017,790 shares at $933.7. March 4 '25 |
| LILLY ENDOWMENT INC filed to sell 96,202,288 shares at $924.5. March 4 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$161.02 1.4% | 53 |
 |
PfizerPFE |
$25.55 2.3% | 39 |
 |
AstrazenecaAZN |
$73.05 1.4% | 55 |
 |
AbbVieABBV |
$201.34 3.7% | 58 |
 |
TherapeuticsMDTXMD |
$0.91 4.6% | 39 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Mar 7, 25 | Sell | $1K - $15K |
| Josh Gottheimer |
Feb 11, 25 | Sell | $1K - $15K |
| Marjorie Taylor Greene |
Jan 28, 25 | Buy | $1K - $15K |
Read more about Eli Lilly and Company (LLY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Eli Lilly and Company?
The Market Cap of Eli Lilly and Company is $777B.
What is Eli Lilly and Company's PE Ratio?
As of today, Eli Lilly and Company's PE (Price to Earnings) ratio is 73.73.
What is the current stock price of Eli Lilly and Company?
Currently, the price of one share of Eli Lilly and Company stock is $852.35.
How can I analyze the LLY stock price chart for investment decisions?
The LLY stock price chart above provides a comprehensive visual representation of Eli Lilly and Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eli Lilly and Company shares. Our platform offers an up-to-date LLY stock price chart, along with technical data analysis and alternative data insights.
Does LLY offer dividends to its shareholders?
Yes, Eli Lilly and Company (LLY) offers dividends to its shareholders, with a dividend yield of 0.72%. This dividend yield represents Eli Lilly and Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Eli Lilly and Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Eli Lilly and Company?
Some of the similar stocks of Eli Lilly and Company are Johnson & Johnson, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.
.